Amenorrhea-galactorrhea syndrome in the prolactin-secreting pituitary tumor: nursing implications.
The amenorrhea-galactorrhea syndrome in prolactin-secreting pituitary tumors is described. The role of prolactin in the development of amenorrhea and galactorrhea is discussed along with the other endocrine abnormalities that overproduction of prolactin may cause. The diagnostic tests that are commonly performed to identify this disease entity are presented with reference to the nurse's role in preparing patients for the diagnostic work-up. Recent advances in transsphenoidal surgery, radiotherapy, and the use of Bromocriptine as therapeutic modalities for this disorder are described. Nursing guidelines that accompany planning care for patients undergoing these treatment regimes are provided.
D000236:Adenoma / Q000378:metabolism* / Q000628:therapy; D000568:Amenorrhea / Q000209:etiology* / Q000451:nursing; D003131:Combined Modality Therapy; D005260:Female; D005687:Galactorrhea / Q000209:etiology* / Q000451:nursing; D006801:Humans; D007775:Lactation Disorders / Q000209:etiology*; D009730:Nursing Assessment; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000628:therapy; D011388:Prolactin / Q000378:metabolism*; D013577:Syndrome
D011388:Prolactin